# Belgian Cross-sectional Allogeneic Transplant Survivor Study

> **NCT02312830** · — · ENROLLING_BY_INVITATION · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 400 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation, Allogeneic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02312830
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2014-11
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312830, "Belgian Cross-sectional Allogeneic Transplant Survivor Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02312830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*